Oncodesign Precision Medicine (XPAR:ALOPM) Total Current Assets : €2.84 Mil (As of Jun. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Oncodesign Precision Medicine's total current assets for the quarter that ended in Jun. 2022 was €2.84 Mil.

Oncodesign Precision Medicine Total Current Assets Historical Data

The historical data trend for Oncodesign Precision Medicine's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Total Current Assets Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Total Current Assets

11.21

6.53

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22
Total Current Assets	11.21	6.53	2.84

Oncodesign Precision Medicine Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Oncodesign Precision Medicine's Total Current Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	4.921	+	1.553	+	0	+	0.051
	=	6.53

Oncodesign Precision Medicine's Total Current Assets for the quarter that ended in Jun. 2022 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.501	+	1.176	+	0	+	0.164
	=	2.84

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Oncodesign Precision Medicine (XPAR:ALOPM) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Oncodesign Precision Medicine's Liquidation Value for the quarter that ended in Jun. 2022 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.501	-	3.906	+	0.75 * 0.439	+	0.5 * 0
=	-2.08

Oncodesign Precision Medicine Total Current Assets Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines